Molecular genetic and immunohistochemical analysis of the tumor suppressor genes Rb and p53 in palmar and aggressive fibromatosis

Diagnostic Molecular Pathology

Volumn 5, Issue 3, 1996, Pages 194-200

  Muller, Elkay ^a   Castagnaro, Massimo ^a   Yandel, David W ^b   Wolfe, Hubert J ^a   Alman, Benjamin A ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Aggressive fibromatosis; Immunohistochemistry; p53; Palmar fibromatosis; PCR; Rb; SSCP

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ARTICLE; DUPUYTREN CONTRACTURE; FIBROMATOSIS; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

BLOTTING, SOUTHERN; DUPUYTREN'S CONTRACTURE; FIBROMATOSIS, AGGRESSIVE; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN; RNA-DIRECTED DNA POLYMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029835566     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199609000-00008     Document Type: Article

References (36)

1. Alman BA, Goldberg MJ, Naber SP, Galanopoulous T, Antoniades HN, Wolfe HJ. Aggressive fibromatosis. J Pediatr Orthop 1992;12:10.
2. Alman BA, Naber SP, Terek RM, Jiranek WA, Goldberg MJ, Wolfe HJ. Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. J Orthop Res 1995;13:67-77.
3. Bootsma AH, VanEijck C, Schouten KK, et al. Somatostatin receptor positive primary breast tumors: genetic patient and tumor characteristics, Int J Cancer 1993;54:357-62.
4. Bowman F, Peters J, Ragge N, Triche T. Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood. Diagn Mol Pathol 1993;2:14-22.
5. Cairns P, Proctor AJ, Knowles MA. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 1991;6:2305-9.
6. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 1990;323:1457-62.
7. Castagnoro M, Yandell DW, Dockhorn-Dworniczak B, Wolfe HJ, Poremda C. Angrogen reception gene mutations and p53 gene analysis in advanced prostate cancer. Verh Dtsch Ges Pathol 1993;77:119-23.
8. Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D. P53 expression in breast cancer. Int J Cancer 1988;41:178-83.
9. Chang MW, Barr E, Seltzer J, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995; 267:518-22.
10. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
11. Chui HF, McFarlane RM. Pathogenesis of Dupuytren's Contracture: a correlative clinico-pathological study. J Hand Surg 1978;3:1-10.
12. Cuveas EC, Bateman AC, Wilkins BS, et al. Microwave antigen retrieval in immunohistochemistry: a study of 80 antibodies. J Clin Pathol 1994;47:448-52.
13. Dal Clin P, Sciot R, Aly MS, et al. Some desmoid tumors are characterized by trisomy 8. Genes Chromosomes Cancer 1994;10:131-5.
14. Fort P, Marty L, Piechaczk M, et al. Various rat tissues express only one major mRNA species for glyceraldehyde 3-phosphate-dehydrogenase family. Nucleic Acids Res 1985; 13:1431-42.
15. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-6.
16. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumors in familial adenomatous polyposis. Gut 1994;35:377-81.
17. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-21.
18. Isobe M, Emanuel BS, Griul D, Oren M, Croce CM. Localization of gene for human p53 tumor antigen to band 17 p 13. Nature 1986;320:84-5.
19. Kupryjaczk J, Thor AD, Beuchamp R, Edgerton SM, Bell DA, Yandell DW. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 1993;90:4961-5.
20. Lambkin HA, Mothersill CM, Kelehan P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 1994;172:13-8.
21. Lattes R. Benign tumors and tumor like proliferations, fibroblastic tumors (fibromatoses). In: Latte R, ed. Tumors of the soft tissues, Washington, DC: Armed Forces Institute of Pathology, 1980:1-30.
22. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee HP. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987;235:1394-9.
23. Liu Y, Szskely L, Grander D, et al. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci USA 1993;90:8697-701.
24. Logothetiis CJ, Xu HJ, Ro JY, et al. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992; 84:1256-61.
25. Maniatis T, Fritsh J, Sambrook J, eds. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1982:931-46.
26. Mihara K, Cao XR, Yen A, et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989;246:1300.
27. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Coexistence of somatic and germ line mutations of APC in desmoid tumors from patients with familial polyposis. Cancer Res 1993;53:5079-82.
28. Nakai H, Misawa S, Togushica J, Yandell DW, Ishizaki K. Frequent q53 gene mutations in blast crisis of chronic myelongenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Res 1992;52:6588-93.
29. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the q53 gene occur in diverse human tumor types. Nature 1989; 343:705-8.
30. Oshio Y, Fukuda T, Tsuneyoshi M. Fibrosarcoma versus fibromatoses and cellular nodular fascitis. A comparative study of their proliferative activity using proliferating nuclear antigen, DNA flow cytometry, and p53. Am J Surg Pathol 1994;18:12-9.
31. Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC. p53 expression in colorectal tumors. Am J Pathol 1991;138:807-13.
32. Sakai T, Toguchida J, Ohtain N, Yandell DW, Rupaport JM, Dryja TP. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 1991;48: 880-8.
33. Toguchida J, Yamaguchi T, Ritchie B, et al. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 192;52:6194-9.
34. Wolfe HJ. Probing for prognostic markers at the cellular level: potentials and pitfalls. J Natl Cancer Inst 1992;19: 1251-6.
35. Yandell DW, Campbell TA, Dayton SH, et al. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med 1989;321: 1689-5.
36. Yandel DW, Dryja TP. Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet 1989;45:547-55.